Riskpilot← Back to searchSign inGet full accessDELTAKLINIKKEN AS
ASActiveOrg 989827561Hammaren 23, 4056 TanangerGeneral medical practice activities · NACE 8621Est. 20064 employeeswww.deltaklinikken.no
Revenue 2024
NOK 6,7M
+6% vs 2023
EBITDA margin
21.8%
-2% vs 2023
Equity ratio
47.9%
Financial strength
Net profit 2024
NOK 1,1M
-2% vs 2023
| Revenue | NOK 6,7M | +6% |
| EBITDA | NOK 1,5M | -2% |
| Net profit | NOK 1,1M | -2% |
| Total assets | NOK 2,8M | +6% |
| Equity | NOK 1,4M | +25% |
| Employees | 4 | — |
Legal name
DELTAKLINIKKEN AS
Org number
989827561
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
20. mai 2006
Share capital
NOK 100 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. John inge lønset netland
Company purpose
Utøve regionalt medisinsk kompetansesenter med tverrfaglig spekter av tjenester innen bedriftshelsetjeneste, spesialistvurdering og fastlege praksis. Selskapet kan også delta i øvrig virksomhet hva hermed er forbunnet med.
Address
Hammaren 23, 4056 Tananger
Phone
+4751646780
Email
post@deltaklinikken.no
Website
www.deltaklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 334 | 5 885 | 5 606 | 6 326 | 6 693 |
| Staff expenses | −1 114 | −1 413 | −1 138 | −1 011 | −1 080 |
| EBITDA | 911 | 1 148 | 1 016 | 1 493 | 1 456 |
| Depreciation & amort. | −12 | −65 | −81 | −87 | −117 |
| EBIT | 900 | 1 083 | 934 | 1 406 | 1 339 |
| Net financials | 0 | 0 | −1 | 1 | 37 |
| Profit before tax | 900 | 1 083 | 934 | 1 408 | 1 376 |
| Tax | −0 | 221 | 207 | 309 | 300 |
| Net profit | 900 | 862 | 726 | 1 099 | 1 076 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 194 | 1 509 | 1 989 | 2 691 | 2 849 |
| Equity | 101 | 463 | 689 | 1 088 | 1 364 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 092 | 1 046 | 1 299 | 1 604 | 1 486 |
| Total debt | 1 092 | 1 046 | 1 299 | 1 604 | 1 486 |
EBITDA margin
21.8%
This company
15.8%
Market median
+38% vs market
20202024
Equity ratio
47.9%
This company
38.2%
Market median
+25% vs market
20202024
Return on equity
78.9%
This company
18.4%
Market median
+329% vs market
20202024
Net profit margin
16.1%
This company
8.1%
Market median
+99% vs market
20202024
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
20202024
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JI Chief Executive Officer | Chief Executive Officer | 2016 |
AØ Deputy Member | Deputy Member | 2006 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DELTAKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Inge Lønset Netland | Chief Executive Officer | 0 companies |
| Annette Øverland | Deputy Member | 0 companies |